186 related articles for article (PubMed ID: 32939321)
1. An integrated classifier improves prognostic accuracy in non-metastatic gastric cancer.
Xing X; Jia S; Leng Y; Wang Q; Li Z; Dong B; Guo T; Cheng X; Du H; Hu Y; Feng Q; Lian S; Luan F; Ma X; Li Z; Ni M; Li Z; Ji J
Oncoimmunology; 2020 Aug; 9(1):1792038. PubMed ID: 32939321
[TBL] [Abstract][Full Text] [Related]
2. An Immune Cell Signature Is Associated With Disease-Free Survival and Adjuvant Chemosensitivity of Patients With Resectable Gastric Cancer.
Yan H; Chen Y; Yang Z; Li Z; Che X; Xiao J; Liu Y; Qu X
Front Immunol; 2020; 11():621623. PubMed ID: 33613554
[TBL] [Abstract][Full Text] [Related]
3. Predictive test for chemotherapy response in resectable gastric cancer: a multi-cohort, retrospective analysis.
Cheong JH; Yang HK; Kim H; Kim WH; Kim YW; Kook MC; Park YK; Kim HH; Lee HS; Lee KH; Gu MJ; Kim HY; Lee J; Choi SH; Hong S; Kim JW; Choi YY; Hyung WJ; Jang E; Kim H; Huh YM; Noh SH
Lancet Oncol; 2018 May; 19(5):629-638. PubMed ID: 29567071
[TBL] [Abstract][Full Text] [Related]
4. ImmunoScore Signature: A Prognostic and Predictive Tool in Gastric Cancer.
Jiang Y; Zhang Q; Hu Y; Li T; Yu J; Zhao L; Ye G; Deng H; Mou T; Cai S; Zhou Z; Liu H; Chen G; Li G; Qi X
Ann Surg; 2018 Mar; 267(3):504-513. PubMed ID: 28002059
[TBL] [Abstract][Full Text] [Related]
5. Immunomarker Support Vector Machine Classifier for Prediction of Gastric Cancer Survival and Adjuvant Chemotherapeutic Benefit.
Jiang Y; Xie J; Han Z; Liu W; Xi S; Huang L; Huang W; Lin T; Zhao L; Hu Y; Yu J; Zhang Q; Li T; Cai S; Li G
Clin Cancer Res; 2018 Nov; 24(22):5574-5584. PubMed ID: 30042208
[No Abstract] [Full Text] [Related]
6. Prognostic and predictive value of a microRNA signature in stage II colon cancer: a microRNA expression analysis.
Zhang JX; Song W; Chen ZH; Wei JH; Liao YJ; Lei J; Hu M; Chen GZ; Liao B; Lu J; Zhao HW; Chen W; He YL; Wang HY; Xie D; Luo JH
Lancet Oncol; 2013 Dec; 14(13):1295-306. PubMed ID: 24239208
[TBL] [Abstract][Full Text] [Related]
7. Comparison of five tumor regression grading systems for gastric adenocarcinoma after neoadjuvant chemotherapy: a retrospective study of 192 cases from National Cancer Center in China.
Zhu Y; Sun Y; Hu S; Jiang Y; Yue J; Xue X; Yang L; Xue L
BMC Gastroenterol; 2017 Mar; 17(1):41. PubMed ID: 28292272
[TBL] [Abstract][Full Text] [Related]
8. A Four-Factor Immunoscore System That Predicts Clinical Outcome for Stage II/III Gastric Cancer.
Wen T; Wang Z; Li Y; Li Z; Che X; Fan Y; Wang S; Qu J; Yang X; Hou K; Zhou W; Xu L; Li C; Wang J; Liu J; Chen L; Zhang J; Qu X; Liu Y
Cancer Immunol Res; 2017 Jul; 5(7):524-534. PubMed ID: 28619967
[TBL] [Abstract][Full Text] [Related]
9. Combination of lymphovascular invasion and the AJCC TNM staging system improves prediction of prognosis in N0 stage gastric cancer: results from a high-volume institution.
Lu J; Dai Y; Xie JW; Wang JB; Lin JX; Chen QY; Cao LL; Lin M; Tu RH; Zheng CH; Li P; Huang CM
BMC Cancer; 2019 Mar; 19(1):216. PubMed ID: 30857518
[TBL] [Abstract][Full Text] [Related]
10. A novel prognostic model based on epithelial-mesenchymal transition-related genes predicts patient survival in gastric cancer.
Song W; Bai Y; Zhu J; Zeng F; Yang C; Hu B; Sun M; Li C; Peng S; Chen M; Sun X
World J Surg Oncol; 2021 Jul; 19(1):216. PubMed ID: 34281542
[TBL] [Abstract][Full Text] [Related]
11. Single Patient Classifier Assay, Microsatellite Instability, and Epstein-Barr Virus Status Predict Clinical Outcomes in Stage II/III Gastric Cancer: Results from CLASSIC Trial.
Roh CK; Choi YY; Choi S; Seo WJ; Cho M; Jang E; Son T; Kim HI; Kim H; Hyung WJ; Huh YM; Noh SH; Cheong JH
Yonsei Med J; 2019 Feb; 60(2):132-139. PubMed ID: 30666834
[TBL] [Abstract][Full Text] [Related]
12. System Analysis Based on Lipid-Metabolism-Related Genes Identifies AGT as a Novel Therapy Target for Gastric Cancer with Neoadjuvant Chemotherapy.
Zhu L; Ma M; Zhang L; Wang S; Guo Y; Ling X; Lin H; Lai N; Lin S; Du L; Dong Q
Pharmaceutics; 2023 Mar; 15(3):. PubMed ID: 36986671
[TBL] [Abstract][Full Text] [Related]
13. Expression Status And Prognostic Value Of M6A-associated Genes in Gastric Cancer.
Guan K; Liu X; Li J; Ding Y; Li J; Cui G; Cui X; Sun R
J Cancer; 2020; 11(10):3027-3040. PubMed ID: 32226518
[No Abstract] [Full Text] [Related]
14. Combination of preoperative plasma fibrinogen and AJCC staging improves the accuracy of survival prediction for patients with stage I-II gastric cancer after curative gastrectomy.
Ding P; Zheng C; Cao G; Gao Z; Lei Y; Deng P; Hou B; Li K
Cancer Med; 2019 Jun; 8(6):2919-2929. PubMed ID: 31050218
[TBL] [Abstract][Full Text] [Related]
15. Individualized prediction of survival benefits from perioperative chemoradiotherapy for patients with resectable gastric cancer.
Che K; Liu F; Wu N; Liu Q; Yuan L; Wei J
Cancer Med; 2020 Oct; 9(19):7137-7150. PubMed ID: 32810384
[TBL] [Abstract][Full Text] [Related]
16. An immune checkpoint score system for prognostic evaluation and adjuvant chemotherapy selection in gastric cancer.
Wang JB; Li P; Liu XL; Zheng QL; Ma YB; Zhao YJ; Xie JW; Lin JX; Lu J; Chen QY; Cao LL; Lin M; Liu LC; Lian NZ; Yang YH; Huang CM; Zheng CH
Nat Commun; 2020 Dec; 11(1):6352. PubMed ID: 33311518
[TBL] [Abstract][Full Text] [Related]
17. A clinical prognostic scoring system for resectable gastric cancer to predict survival and benefit from paclitaxel- or oxaliplatin-based adjuvant chemotherapy.
Qian J; Qian Y; Wang J; Gu B; Pei D; He S; Zhu F; Røe OD; Xu J; Liu L; Gu Y; Guo R; Yin Y; Shu Y; Chen X
Drug Des Devel Ther; 2016; 10():241-58. PubMed ID: 26966350
[TBL] [Abstract][Full Text] [Related]
18. [A multi-center retrospective study of perioperative chemotherapy for gastric cancer based on real-world data].
Ding XW; Zheng ZC; Zhao Q; Zhai G; Liang H; Wu X; Zhu ZG; Wang HJ; He QS; He XL; Du YA; Chen LC; Hua YW; Huang CM; Xue YW; Zhou Y; Zhou YB; Wu D; Fang XD; Dai YG; Zhang HW; Cao JQ; Li LP; Chai J; Tao KX; Li GL; Jie ZG; Ge J; Xu ZF; Zhang WB; Li QY; Zhao P; Ma ZQ; Yan ZL; Zheng GL; Yan Y; Tang XL; Zhou X
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 May; 24(5):403-412. PubMed ID: 34000769
[No Abstract] [Full Text] [Related]
19. Modified ypTNM Staging Classification for Gastric Cancer after Neoadjuvant Therapy: A Multi-Institutional Study.
Zhong Q; Chen QY; Parisi A; Ma YB; Lin GT; Desiderio J; Yan S; Xie JW; Wang JB; Hou JF; Lin JX; Lu J; Cao LL; Lin M; Tu RH; Huang ZN; Lin JL; Liu ZY; Que SJ; Li P; Zheng CH; Huang CM
Oncologist; 2021 Jan; 26(1):e99-e110. PubMed ID: 32864840
[TBL] [Abstract][Full Text] [Related]
20. Blood parameters score predicts long-term outcomes in stage II-III gastric cancer patients.
Lin JX; Tang YH; Wang JB; Lu J; Chen QY; Cao LL; Lin M; Tu RH; Huang CM; Li P; Zheng CH; Xie JW
World J Gastroenterol; 2019 Nov; 25(41):6258-6272. PubMed ID: 31749596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
